Stock Analysis

3 Top KRX Growth Companies With High Insider Ownership

KOSE:A352820
Source: Shutterstock

The South Korean stock market has faced recent declines, with the KOSPI index retreating over 2 percent amid geopolitical tensions in the Middle East and mixed performances in global markets. Despite these challenges, growth companies with high insider ownership can offer stability and potential resilience, making them noteworthy in uncertain times.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.4%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.5%52.1%
Bioneer (KOSDAQ:A064550)15.8%97.6%
Oscotec (KOSDAQ:A039200)26.1%122%
Vuno (KOSDAQ:A338220)19.5%110.9%
HANA Micron (KOSDAQ:A067310)18.3%100.3%
Park Systems (KOSDAQ:A140860)33%35.6%
UTI (KOSDAQ:A179900)33.1%134.6%
Techwing (KOSDAQ:A089030)18.7%83.6%
INTEKPLUS (KOSDAQ:A064290)16.3%96.7%

Click here to see the full list of 87 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

JUSUNG ENGINEERINGLtd (KOSDAQ:A036930)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: JUSUNG ENGINEERING Co., Ltd. manufactures and sells semiconductor, display, solar, and lighting equipment in South Korea and internationally, with a market cap of approximately ₩1.27 trillion.

Operations: Revenue from semiconductor equipment and services amounted to approximately ₩338.28 billion.

Insider Ownership: 36.9%

Earnings Growth Forecast: 21% p.a.

JUSUNG ENGINEERING Ltd. is trading at 34.7% below its estimated fair value, presenting a potential investment opportunity. The company has strong growth prospects with revenue expected to grow at 21.7% per year, outpacing the South Korean market average of 10.5%. Although earnings are forecast to grow at 21% annually, this is slower than the market's expected rate of 29.7%. Notably, there has been substantial insider ownership with no significant insider selling reported recently.

KOSDAQ:A036930 Earnings and Revenue Growth as at Oct 2024
KOSDAQ:A036930 Earnings and Revenue Growth as at Oct 2024

Vuno (KOSDAQ:A338220)

Simply Wall St Growth Rating: ★★★★★★

Overview: Vuno Inc. is a medical artificial intelligence (AI) solution development company with a market cap of approximately ₩470.12 billion.

Operations: Vuno Inc. generates revenue primarily from artificial intelligence medical software production, amounting to ₩20.42 billion.

Insider Ownership: 19.5%

Earnings Growth Forecast: 110.9% p.a.

Vuno is trading at 2.2% below its estimated fair value, with revenue expected to grow at 40.4% per year, significantly outpacing the South Korean market average of 10.5%. Despite recent shareholder dilution and high share price volatility, earnings are forecast to grow at an impressive rate of 110.92% annually. The company is expected to become profitable within three years, and its Return on Equity is projected to be very high in that timeframe.

KOSDAQ:A338220 Ownership Breakdown as at Oct 2024
KOSDAQ:A338220 Ownership Breakdown as at Oct 2024

HYBE (KOSE:A352820)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management with a market cap of ₩7.03 trillion.

Operations: Revenue segments for HYBE Co., Ltd. include Label at ₩1.28 trillion, Platform at ₩361.12 million, and Solution at ₩1.24 trillion.

Insider Ownership: 32.5%

Earnings Growth Forecast: 42.2% p.a.

HYBE's earnings are forecast to grow 42.23% annually, significantly outpacing the South Korean market. The company recently completed a buyback of 150,000 shares for KRW 26.09 billion to stabilize its stock price. Despite a drop in net income and basic earnings per share compared to last year, HYBE trades at 27.8% below its estimated fair value, with analysts agreeing on a potential price rise of 51.9%.

KOSE:A352820 Earnings and Revenue Growth as at Oct 2024
KOSE:A352820 Earnings and Revenue Growth as at Oct 2024

Turning Ideas Into Actions

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if HYBE might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com